CorrectionErratum
Correction to “TD-19, an Erlotinib Derivative, Induces Epidermal Growth Factor Receptor Wild-Type Nonsmall-Cell Lung Cancer Apoptosis through CIP2A-Mediated Pathway”
Journal of Pharmacology and Experimental Therapeutics January 2018, 364 (1) 26-27; DOI: https://doi.org/10.1124/jpet.117.215418err